MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.

Medprin Regenerative Medical Technologies Co., Ltd.

Equities

301033

CNE100004NB8

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
39.11 ^CNY	+0.85%		+0.18%	-10.17%

20/06	Medprin Regenerative Medical Technologies Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 26 June 2024	CI
13/05	Medprin Regenerative Medical Technologies Co., Ltd. Approves Board Appointments	CI

Medprin Regenerative Medical Technologies Co., Ltd. has completed an IPO in the amount of CNY 250.048697 million.

July 15, 2021 at 09:30 am IST

Medprin Regenerative Medical Technologies Co., Ltd. has completed an IPO in the amount of CNY 250.048697 million.

Security Name: A Shares
Security Type: Common Stock
Securities Offered: 16,515,766
PriceRange: CNY 15.14

Transaction Features: Sponsor Backed Offering

Latest news about Medprin Regenerative Medical Technologies Co., Ltd.

Medprin Regenerative Medical Technologies Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 26 June 2024	21/06	CI
Medprin Regenerative Medical Technologies Co., Ltd. Approves Board Appointments	14/05	CI
Medprin Regenerative Medical Technologies Co., Ltd. Approves Cash Dividend for the Year 2023	14/05	CI
Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.	10/05	CI
Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback announced on February 23, 2024, has closed with 352,500 shares, representing 0.54% for CNY 11.5 million.	10/05	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	18/04	CI
Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.	02/04	CI
Medprin Regenerative Medical Technologies Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	23/02	CI
Medprin Regenerative Medical Technologies Co., Ltd. authorizes a Buyback Plan.	22/02	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2023.	26/23/26	CI
Medprin Regenerative Medical Technologies Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 01 June 2023	20/23/20	CI
Medprin Regenerative Medical Technologies Co., Ltd. Proposes Profit Distribution of Cash Dividend for the Year 2022	28/23/28	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Medprin Regenerative Medical Gets Marketing Nod in China for Craniofacial Fixation Plate	14/23/14	MT
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/22/26	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	12/22/12	CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2022.	26/22/26	CI
Medprin Regenerative Medical Technologies to Free Up 2.5% Stake For Trading	22/22/22	MT
Medprin Regenerative Medical Technologies Co., Ltd. Approves Profit Distribution Plan for 2021	14/22/14	CI
Medprin Regenerative Medical Technologies Co., Ltd. Announces Profit Distribution for 2021	22/22/22	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/22/20	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI

Chart Medprin Regenerative Medical Technologies Co., Ltd.

Duration

Period

Chart Medprin Regenerative Medical Technologies Co., Ltd.

More charts

Company Profile

Medprin Regenerative Medical Technologies Co Ltd is a China-based company principally engaged in the research and development, production and sales of high-performance implantable medical devices. The Company's implanted medical device products include artificial dura mater (spine) patch, cranio-maxillofacial repair products and absorbable hemostatic yarns. 3D printing equipment includes biological 3D printers, resin 3D printers and other related supporting components. Technical services include general technical services and scientific research services. The Company distributes its products both in the domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

16/07/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.	-10.17%	36Cr
STRYKER CORPORATION	+13.62%	13TCr
SMITH & NEPHEW PLC	-9.08%	1.08TCr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-18.14%	712.39Cr
GLAUKOS CORPORATION	+48.89%	646.11Cr
INSPIRE MEDICAL SYSTEMS, INC.	-34.21%	397.62Cr
AXONICS, INC.	+8.03%	343Cr
ENOVIS CORPORATION	-19.31%	247.93Cr
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-18.50%	190.75Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-24.94%	166.31Cr

Medical Devices & Implants